NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-495-2013-0-IE-01 Anti-Human Papillomavirus 16 E6 T Cell Receptors IE EP 19180239.6 Issued
NCI E-495-2013-0-DE-01 Anti-Human Papillomavirus 16 E6 T Cell Receptors DE EP 19180239.6 Issued
NCI E-495-2013-0-FR-01 Anti-Human Papillomavirus 16 E6 T Cell Receptors FR EP 19180239.6 Issued
NCI E-060-2018-0-PCT-02 CANCER TREATMENT METHODS PCT PCT PCT/US2019/037204 Expired
NCI E-062-2018-0-PCT-02 METHODS OF TREATING HBV PCT PCT PCT/US2019/037184 Expired
NICHD E-026-2019-0-PCT-02 POLYPEPTIDES, NUCLEIC ACID MOLECULES, COMPOSITIONS, AND RELATED METHODS PCT PCT PCT/US2019/037169 Expired
NCI E-250-2016-0-US-04 METHODS OF PREPARING AN ISOLATED OR PURIFIED POPULATION OF THYMIC EMIGRANT CELLS AND MEHTODS OF TREATMENT USING SAME US National Stage 16/468,890 12215349 Issued PDF
NIAAA E-282-2012-1-US-09 CANNABINOID RECEPTOR MEDIATING COMPOUNDS US CON 16/438,850 Abandoned
NHGRI E-044-2013-0-JP-15 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin JP DIV 2019-109410 Abandoned
NINDS E-130-2022-3-NZ-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE NZ National Stage 754522 Pending
NCI E-250-2016-0-EP-03 METHODS OF PREPARING AN ISOLATED OR PURIFIED POPULATION OF THYMIC EMIGRANT CELLS AND METHODS OF TREATMENT USING SAME EP National Stage 17825696.2 Issued
NCI E-291-2012-0-CN-23 M971 Chimeric Antigen Receptors CN DIV 201910500128.7 Issued
NIAID E-174-2017-1-US-06 Protection Of Calves By A Prefusion-stabillze Bovine RSV Vaccine US National Stage 16/468,174 11084850 Issued PDF
NEI E-162-2016-0-US-08 RPGR GENE THERAPY FOR RETINITIS PIGMENTOSA US CON 16/436,521 11045558 Issued PDF
NIAID E-124-2018-0-PCT-02 NEW COMPOSITIONS AND DETECTION METHODS FOR ONCHOCERCA VOLVULUS INFECTION PCT PCT PCT/US2019/036382 Expired
NINDS E-130-2022-3-US-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE US National Stage 16/467,721 12168008 Issued PDF
NCI E-021-2015-0-EP-09 Anti-CD70 Chimeric Antigen Receptors EP DIV 19178931.2 Issued
NCI E-021-2015-0-GB-48 Anti-CD70 Chimeric Antigen Receptors GB EP 19178931.2 Issued
NCI E-021-2015-0-NO-44 Anti-CD70 Chimeric Antigen Receptors NO EP 19178931.2 Issued
NCI E-021-2015-0-NL-43 Anti-CD70 Chimeric Antigen Receptors NL EP 19178931.2 Issued
NCI E-021-2015-0-IT-42 Anti-CD70 Chimeric Antigen Receptors IT EP 19178931.2 Issued
NCI E-021-2015-0-DK-39 Anti-CD70 Chimeric Antigen Receptors DK EP 19178931.2 Issued
NCI E-021-2015-0-FR-40 Anti-CD70 Chimeric Antigen Receptors FR EP 19178931.2 Issued
NCI E-021-2015-0-DE-41 Anti-CD70 Chimeric Antigen Receptors DE EP 19178931.2 Issued
NCI E-021-2015-0-BE-38 Anti-CD70 Chimeric Antigen Receptors BE EP 19178931.2 Issued
NCI E-021-2015-0-SE-46 Anti-CD70 Chimeric Antigen Receptors SE EP 19178931.2 Issued
NCI E-021-2015-0-ES-45 Anti-CD70 Chimeric Antigen Receptors ES EP 19178931.2 Issued
NCI E-021-2015-0-CH-47 Anti-CD70 Chimeric Antigen Receptors CH EP 19178931.2 Issued
NCI E-169-2016-0-EP-05 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS EP National Stage 17 808 241.8 Issued
NCI E-169-2016-0-GB-11 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS GB EP 17 808 241.8 Issued
NCI E-169-2016-0-CH-07 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS CH EP 17 808 241.8 Issued
NCI E-169-2016-0-ES-09 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS ES EP 17 808 241.8 Issued
NCI E-169-2016-0-IT-13 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS IT EP 17 808 241.8 Issued
NCI E-169-2016-0-NL-14 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS NL EP 17 808 241.8 Issued
NCI E-169-2016-0-FR-10 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS FR EP 17 808 241.8 Issued
NCI E-169-2016-0-DE-08 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS DE EP 17 808 241.8 Issued
NCI E-169-2016-0-IE-12 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS IE EP 17 808 241.8 Issued
NINDS E-130-2022-3-IL-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE IL National Stage 267134 Issued
NCATS E-096-2018-0-JP-07 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine JP National Stage 2020-567577 Issued
NCATS E-096-2018-0-CN-05 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine CN National Stage 201980042389.7 Issued
NCATS E-096-2018-0-AU-03 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine AU National Stage 2019282560 Issued
NCATS E-096-2018-0-IT-01 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine IT EP 19732189.6 Issued
NCATS E-096-2018-0-DE-01 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine DE EP 19732189.6 Issued
NCATS E-096-2018-0-ES-01 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine ES EP 19732189.6 Issued
NCATS E-096-2018-0-FR-01 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine FR EP 19732189.6 Issued
NCATS E-096-2018-0-GB-01 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine GB EP 19732189.6 Issued
NCATS E-096-2018-0-EP-06 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine EP National Stage 19732189.6 Issued
NCATS E-096-2018-0-PCT-02 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine PCT PCT PCT/US2019/035360 Expired
NIA E-061-2019-0-US-01 INHIBITORS OF LRP1-DKK PROTEIN COMPLEX TO PROMOTE CLEARANCE OF AMYLOID-BETA US 62/857,204 Abandoned
NCATS E-096-2018-0-CA-04 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine CA National Stage 3102387 Pending